Topic
Gilead Sciences
2 stories related to this topic, newest first.
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)science27 days ago
Biotech Developments Include Duchenne Drug Class, Gilead Acquisitions and Industry Updates
A class of drugs for Duchenne muscular dystrophy has drawn attention in recent discussions. Gilead Sciences continues its series of mergers and acquisitions in the biotech sector. Additional news covers ongoing advancements and regulatory matters in biotechnology.
ST
Anna Zvereva from Tallinn, Estonia / Wikimedia (CC BY-SA 2.0)science28 days ago
Gilead Sciences Acquires German Biotech Tubulis for Over $3 Billion
Gilead Sciences announced the acquisition of Tubulis, a German biotechnology company, for more than $3 billion. The deal aims to expand Gilead's oncology drug development pipeline. Tubulis specializes in antibody-drug conjugates for cancer treatments.
ST